1. Home
  2. EVO vs CSWC Comparison

EVO vs CSWC Comparison

Compare EVO & CSWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • CSWC
  • Stock Information
  • Founded
  • EVO 1993
  • CSWC 1961
  • Country
  • EVO Germany
  • CSWC United States
  • Employees
  • EVO N/A
  • CSWC N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • CSWC Textiles
  • Sector
  • EVO Health Care
  • CSWC Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • CSWC Nasdaq
  • Market Cap
  • EVO 1.2B
  • CSWC 1.3B
  • IPO Year
  • EVO 2021
  • CSWC N/A
  • Fundamental
  • Price
  • EVO $3.48
  • CSWC $22.87
  • Analyst Decision
  • EVO Buy
  • CSWC Buy
  • Analyst Count
  • EVO 2
  • CSWC 5
  • Target Price
  • EVO $5.40
  • CSWC $23.70
  • AVG Volume (30 Days)
  • EVO 52.1K
  • CSWC 604.4K
  • Earning Date
  • EVO 11-05-2025
  • CSWC 10-27-2025
  • Dividend Yield
  • EVO N/A
  • CSWC 11.11%
  • EPS Growth
  • EVO N/A
  • CSWC N/A
  • EPS
  • EVO N/A
  • CSWC 1.64
  • Revenue
  • EVO $912,894,891.00
  • CSWC $209,032,000.00
  • Revenue This Year
  • EVO $0.43
  • CSWC $14.15
  • Revenue Next Year
  • EVO $9.72
  • CSWC $10.11
  • P/E Ratio
  • EVO N/A
  • CSWC $14.00
  • Revenue Growth
  • EVO N/A
  • CSWC 10.52
  • 52 Week Low
  • EVO $2.84
  • CSWC $17.46
  • 52 Week High
  • EVO $5.64
  • CSWC $25.90
  • Technical
  • Relative Strength Index (RSI)
  • EVO 39.62
  • CSWC 54.22
  • Support Level
  • EVO $3.36
  • CSWC $22.66
  • Resistance Level
  • EVO $3.52
  • CSWC $23.05
  • Average True Range (ATR)
  • EVO 0.08
  • CSWC 0.28
  • MACD
  • EVO 0.00
  • CSWC 0.03
  • Stochastic Oscillator
  • EVO 31.58
  • CSWC 77.50

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

Share on Social Networks: